Relationship between insulin resistance and dietary intake of vitamins D and E in women with PCOS based on Rotterdam criteria

Document Type : Original Article

Authors

1 M.Sc. in Midwifery, Department of Midwifery and Reproductive Health, School of Medical Sciences, Tarbiat Modares University, Tehran, Iran.

2 Professor, Department of Midwifery and Reproductive Health, Faculty of Medicine, Tarbiat Modares University, Tehran, Iran.

3 Professor, Department of Biostatistics, Faculty of Medicine, Tarbiat Modares University, Tehran, Iran.

4 Instructor, Department of Midwifery, School of Nursing and Midwifery, Neyshabur University of Medical Sciences, Neyshabur, Iran.

Abstract

Introduction: Polycystic Ovary Syndrome (PCOS) is the most common endocrine disorder with oxidative stress in women of reproductive age. Oxidative stress is an important factor in the development of insulin resistance. Some nutrients are linked to oxidative stress. This study was performed with aim to determine the relationship between insulin resistance and dietary intake of vitamins D and E in PCOS subgroups.
Methods: This case-control study was performed in 2015-2016 on 151 women with PCOS who were divided into four groups according to Rotterdam diagnostic criteria (D (H+O) = 37, C (P+O) = 40, B (H+P)= 33, A (H+P+O) = 41 and 31 women in the control group). Daily intake of vitamin D and vitamin E was assessed using a 168 items PPQ food frequency questionnaire. Insulin resistance was diagnosed with HOMA index (Cut off> 2.5). Data were analyzed by SPSS software (version 22) and Kruskal-Wallis, one-way ANOVA, Chi-square and Spearman tests. P<0.05 was considered statistically significant.
Results: In the subgroups of A, D and control group, a significant negative relationship was observed between HOMA insulin resistance index with vitamin D (P = 0.022), (P = 0.049) and (P = 0.025), respectively and with vitamin E (P = 0.036), (P = 0.001) and (P = 0.001), respectively. In the subgroups of B and C, no relationship between HOMA insulin resistance index with vitamin D and vitamin E (P> 0.05).
Conclusion: Due to the relationship between insulin resistance and vitamins D and E in PCOS subtypes, it is recommended to increase the intake of vitamins D and E to improve health parameters in PCOS subjects.

Keywords

References

  1. Legro RS, Arslanian SA, Ehrmann DA, Hoeger KM, Murad MH, Pasquali R, et al. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism 2013; 98(12):4565-92.
  2. Kar S. Anthropometric, clinical, and metabolic comparisons of the four Rotterdam PCOS phenotypes: A prospective study of PCOS women. J Hum Reprod Sci 2013; 6(3):194-200.
  3. Aali B, Naderi T. Evaluation of clinical, ultrasound and laboratory features of PCOS in Kerman in 1381. Iranian Journal of Endocrinology and Metabolism 2004; 6:153-61.
  4. Tehrani FR, Rashidi H, Azizi F. The prevalence of idiopathic hirsutism and polycystic ovary syndrome in the Tehran Lipid and Glucose Study. Reprod Biol Endocrinol 2011; 9:144.
  5. Jalilian A, Kiani F, Sayehmiri F, Sayehmiri K, Khodaee Z, Akbari M. Prevalence of polycystic ovary syndrome and its associated complications in Iranian women: A meta-analysis. Iran J Reprod Med 2015; 13(10):591-604.
  6. Conway G, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Franks S, Gambineri A, et al. The polycystic ovary syndrome: a position statement from the European Society of Endocrinology. Eur J Endocrinol 2014; 171(4):P1-29.
  7. Yildiz BO, Chang W, Azziz R. Polycystic ovary syndrome and ovulation induction. Minerva Ginecol 2003; 55(5):425-39.
  8. Berek JS. Berek & Novak's Gynecology. 15nd ed. Lippincott Williams & Wilkins; 2012. 
  9. Marshall JC, Dunaif A. Should all women with PCOS be treated for insulin resistance? Fertil Steril 2012; 97(1):18-22.
  10. Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med 2010; 8:41.
  11. Salehpour S, Manzor-Al-Ajdad O, Samani EN, Abadi A. Evaluation of homocysteine levels in patients with polycystic ovarian syndrome. Int J Fertil Steril 2011; 4(4):168-71.
  12. Shah P. Polycystic Ovarian Syndrome and Its Association with Vitamin D. Ann Med Medical Res 2018; 1.1008.
  13. Bhattacharya SM, Jha A. Association of vitamin D3 deficiency with clinical and biochemical parameters in Indian women with polycystic ovary syndrome. Int J Gynaecol Obstet 2013; 123(1):74-5.
  14. Muscogiuri G, Mitri J, Mathieu C, Badenhoop K, Tamer G, Orio F, et al. Mechanisms in endocrinology: vitamin D as a potential contributor in endocrine health and disease. Eur J Endocrinol 2014; 171(3):R101-10.
  15. Chung M, Balk EM, Brendel M, Ip S, Lau J, Lee J, et al. Vitamin D and calcium: a systematic review of health outcomes. Evid Rep Technol Assess (Full Rep) 2009; 183(183):1-420.
  16. Thomson RL, Spedding S, Buckley JD. Vitamin D in the aetiology and management of polycystic ovary syndrome. Clin Endocrinol (Oxf) 2012; 77(3):343-50.
  17. Bikle D. Nonclassic actions of vitamin D. J Clin Endocrinol Metab 2009; 94(1):26-34.
  18. Kensara OA. Prevalence of hypovitaminosis D, and its association with hypoadiponectinemia and hyperfollistatinemia, in Saudi women with naïve polycystic ovary syndrome. Journal of clinical & translational endocrinology 2018;12:20-5.
  19. Kim JJ, Choi YM, Chae SJ, Hwang KR, Yoon SH, Kim MJ, et al. Vitamin D deficiency in women with polycystic ovary syndrome. Clinical and experimental reproductive medicine 2014; 41(2):80-5.
  20. Manning PJ, Sutherland WH, Walker RJ, Williams SM, De Jong SA, Ryalls AR, et al. Effect of high-dose vitamin E on insulin resistance and associated parameters in overweight subjects. Diabetes care 2004; 27(9):2166-71.
  21. Dorfman L. Krause's Food & the Nutrition Care Process. Nutrition for Exercise and Sports Performance 2011; 13(24):32-62.
  22. Caballero B. Vitamin E improves the action of insulin. Nutrition reviews 1993; 51(11):339-40.
  23. Mayer-Davis EJ, Costacou T, King I, Zaccaro DJ, Bell RA; Insulin Resistance and Atherosclerosis Study (IRAS). Plasma and dietary vitamin E in relation to incidence of type 2 diabetes: The Insulin Resistance and Atherosclerosis Study (IRAS). Diabetes Care 2002; 25(12):2172-7.
  24. Sirmans SM, Pate KA. Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol 2013; 6:1-13.
  25. Brady C, Mousa SS, Mousa SA. Polycystic ovary syndrome and its impact on women's quality of life: More than just an endocrine disorder. Drug Healthc Patient Saf 2009; 1:9-15.
  26. Hashemi S, Ramezani Tehrani F, Noroozzadeh M, Azizi F. Normal cut-off values for hyperandrogenaemia in Iranian women of reproductive age. Eur J Obstet Gynecol Reprod Biol 2014; 172:51-5.
  27. Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol 2011; 7(4):219-31.
  28. Schorge JO. Williams gynecology. 1nd ed. New York: McGraw-Hill Medical; 2008.
  29. Kim HM, Park J, Ryu SY, Kim J. The effect of menopause on the metabolic syndrome among Korean women: the Korean National Health and Nutrition Examination Survey, 2001. Diabetes Care 2007; 30(3):701-6.
  30. Asghari G, Rezazadeh A, Hosseini-Esfahani F, Mehrabi Y, Mirmiran P, Azizi F. Reliability, comparative validity and stability of dietary patterns derived from an FFQ in the Tehran Lipid and Glucose Study. Br J Nutr 2012; 108(6):1109-17.
  31. Mirmiran P, Esfahani FH, Mehrabi Y, Hedayati M, Azizi F. Reliability and relative validity of an FFQ for nutrients in the Tehran lipid and glucose study. Public Health Nutr 2010; 13(5):654-62.
  32. Hosseini-Esfahani F, Daneshpour MS, Mirmiran P, Mehrabi Y, Hedayati M, Azizi F. Interaction of APOC3 polymorphism and dietary fats on the risk of metabolic syndrome. Iranian Journal of Endocrinology and Metabolism 2015; 16(5):345-55.
  33. Hosseinpanah F, Barzin M, Keihani S, Ramezani Tehrani F, Azizi F. Metabolic aspects of different phenotypes of polycystic ovary syndrome: Iranian PCOS Prevalence Study. Clin Endocrinol (Oxf) 2014; 81(1):93-9.
  34. Moghetti P, Tosi F, Bonin C, Di Sarra D, Fiers T, Kaufman JM, et al. Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome. J Clin Endocrinol Metab 2013; 98(4):E628-37.
  35. Guraya SS, Alhussaini KA, Shaqrun FM, Alhazmi BH, Alkabli RS. Correlation of clinical, radiological and serum analysis of hypovitaminosis D with polycystic ovary syndrome: A systematic review and meta-analysis. J Taibah Univ Med Sci 2017; 12(4):277-283.
  36. Murri M, Luque-Ramírez M, Insenser M, Ojeda-Ojeda M, Escobar-Morreale HF. Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis. Hum Reprod Update 2013; 19(3):268-88.
  37. Foroozanfard F, Talebi M, Samimi M, Mehrabi S, Badehnoosh B, Jamilian M, et al. Effect of Two Different Doses of Vitamin D Supplementation on Metabolic Profiles of Insulin-Resistant Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial. Horm Metab Res 2017; 49(8):612-617.
  38. Gupta T, Rawat M, Gupta N, Arora S. Study of Effect of Vitamin D Supplementation on the Clinical, Hormonal and Metabolic Profile of the PCOS Women. J Obstet Gynaecol India 2017; 67(5):349-355.
  39. Ardabili HR, Gargari BP, Farzadi L. Vitamin D supplementation has no effect on insulin resistance assessment in women with polycystic ovary syndrome and vitamin D deficiency. Nutr Res 2012; 32(3):195-201.
  40. Shidfar F, Rezaei KH, Hosseini Esfahani SH, Heydari I. The effects of vitamin E on insulin resistance and cardiovascular diseases risk factors in metabolic syndrome. Iranian Journal of Endocrinology and Metabolism 2009; 10(5):445-54.
The Iranian Journal of Obstetrics, Gynecology and Infertility
Volume 23, Issue 12
February 2021
Pages 46-56

Files

Share

How to cite

Statistics